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Abstract 
Objective: To document iodine status in Indian pregnancies, associations with maternal diet 
and demographics, and offspring developmental measures. 
Design: Longitudinal study following mothers through pregnancy and offsprings up to 24 
months. 
Setting: Rural healthcare centre (Vadu) and urban antenatal clinic (Pune) in the Maharashtra 
region of India.  
Subjects: Pregnant mothers at 17 (n=132) and 34 weeks (n=151) gestation and their infants 
from birth to the age of 24 months. 
Results: Median urinary iodine concentrations (UIC) were 203µg/L and 211µg/L at 17 and 
34 weeks gestation, respectively (range 26-800µg/L). Using the UIC distribution adjusted for 
within-person variations, extreme UIC quartiles were compared for predictors and outcomes. 
There was no correlation between urinary iodine concentrations at 17 and 34 weeks, but 24% 
of those with low UIC in the lowest quartile at 17 weeks had a UIC in the same lowest 
quartile at 34 weeks. Maternal educational, socio-economic status and milk product 
consumption (frequency) were different between lowest and highest quartile of UIC at 34 
weeks. Selected offspring developmental outcomes differed between lowest and highest UIC 
quartiles (abdominal circumference at 24 months, and subscapular and triceps skinfolds at 12 
and 24 months). However, UIC was only a weak predictor of subscapular skinfold at 12 
months and triceps skinfold at 24 months. 
Conclusions:  Median UIC in this pregnant population suggest adequate dietary provision at 
both gestational stages studied. Occasional high results found in spot samples may indicate 
intermittent consumption of iodine-rich foods. Maternal UIC had limited influence on 
offspring developmental outcome.  
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Background 
Iodine is an essential dietary element, required for the thyroid gland to synthesise thyroxine 
by iodination of tyrosine.  Iodine is present in soil to a variable degree, so found in low 
amounts in many foods. Dairy and sea-foods are rich sources and supply most human iodine 
intake
(1)
. If dietary iodine is insufficient to produce enough thyroxine, blood thyroid 
stimulating hormone (TSH) rises, and the gland enlarges (‘goitre’) to compensate.  If blood 
thyroxine (T4) and its active derivative triiodothyronine (T3) fall, many organs fail to 
function optimally, and classical symptoms of hypothyroidism develop. The impacts of 
hypothyroidism on pregnancy include spontaneous abortion, still birth, peri-natal death and 
stunted growth
(2)
.  
 
Depending on severity, iodine deficiency in pregnancy can cause miscarriage, and ultimately 
infertility.  It can cause neonatal hypothyroidism
(3)
, growth failure
(4) 
,neonatal goitre and 
neurological impediment
(5,6) 
. Iodine is critical for the maturation of the central nervous 
system, particularly for myelination. Brain damage increases with the degree of iodine 
deficiency, the severest consequence being overt cretinism, with severe mental retardation, 
deaf-mutism, stunting, impaired gait and motor function
(7)
. In areas of iodine deficiency 
cretinism may be uncommon, but milder degrees of neurological damage can affect a 
substantial number, and iodine supplementation improves cognition deficient children
(8,9)
. 
Dietary iodine insufficiency is common, in India, with an estimated total of 71 million 
affected in total
(10,11)
. Consumption of few dairy products or seafood and large amounts of 
goitrogen-containing foods may compound this issue
(12)
. Moreover, the Indian soil may be 
more iodine-deficient because of high rainfall and flooding, leading to mineral depletion
 (13)
. 
Iodine deficiency disorders have been tackled in India via the National Iodine Deficiency 
Disorders Control Programme (NIDDCP)
(11,14)
 but iodine status has seldom been considered 
in Indian pregnancies
(15,16)
, with studies focussing on defining iodine deficiency in sub-
populations
(17-19)
. Nevertheless, and despite the effort of the NIDDCP, iodine deficiency 
remains an issue in some regions
(38,39)
. The prevalence of iodine deficiency may, however, 
have been overstated due to misunderstanding of the terminology used in the WHO 
statement
(20)
. 
While iodized salt is available in India, with some states having even banned the use of non-
iodized salt, salt iodisation (as well as its impact) is still unreliable, in part due to access 
(20-
22)
. Indeed, the worldwide National Family Health Survey (NFHS-3) 2005–2006 revealed that 
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only 51% of households in India consume iodized salt
(23)
. Furthermore, general health 
recommendations are to avoid adding salt to foods. Adequately iodized salt contains ≥ 15ppm 
but according to a recent Indian study, only 17% household edible salt samples contained the 
stipulated iodine content of >15ppm when measured by a titration method
(24)
. 
 
There is substantial iodine storage, as iodo-tyrosines in the thyroid, so consumption is not 
required daily. Iodine supplementation or food fortification can normalise TSH
(25)
, reduce 
endemic goitre, and normalize thyroid metabolism
(26,27).
  Individual dietary requirements 
vary: non pregnant adults have a mean requirement of 95µg/day
(28)
. Goitre, indicating severe 
deficiency, is found with iodine intakes below 50µg/day
(29) 
. WHO guidelines, classify the 
severity of iodine deficiency in populations according to median urinary iodine 
concentrations 100 µg/L, as the lower limit of acceptability for non-pregnant adults
(30) 
.  
During pregnancy and lactation, requirements are increased. Although T4 is usually 
converted in tissues to the more active T3, thyroxine itself is required by the developing brain 
throughout pregnancy
(8)
 . In the first trimester, partial transfer of thyroxine through the 
placenta to the fetus is essential for fetal neurological development. Later, the fetal thyroid 
develops sufficiently to produce its own thyroxine, for which extra maternal iodine is still 
required
(31)
 . Dietary requirement may be increased by increased renal clearance in pregnancy 
and lactation
(32)
 and dietary iodine intake during pregnancy and lactation have recently been 
revised by the WHO and ICCIDD to 250 µg/day
(30)
. Dietary iodine intake is difficult to 
measure, and urinary iodine (UI) is used as the preferred marker for population iodine status 
(as approximately 90% of the iodine ingested is excreted), with a lower limit of 150µg/l as a 
threshold for sufficiency for the pregnant population
(30)  
(Table 1).  
 
The present study investigated the iodine status of a pregnant Indian population living in both 
rural and urban settings, in the Maharashtra region of India, at different stages of pregnancy 
and the potential for low/marginal maternal iodine status to subtly impair fetal growth and 
development, without frank hypothyroidism. This may be important because small-for-dates 
(included in low-birth weight) babies are more likely to develop hypertension, diabetes and 
related “metabolic syndrome” disorders in adult life(33). Indian women tend to have small 
babies
(34,35) 
and Indians are particularly prone to metabolic syndrome
(34,36)
, which has an 
association with subclinical hypothyroidism
(37)
 and with multinodular goitre in regions with 
iodine deficiency
(38,39)
.  
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Study design and methods 
This design of this study is longitudinal, with a follow-up of mothers during pregnancy, and 
follow-up of their infants from birth to 24 months of age (part of a larger IAEA-funded study
 
(40) 
on determinants of subsequent metabolic syndrome). We recruited 234 healthy pregnant 
women who agreed to participate during May 2004 to July 2006: 118 pregnant women from a 
rural primary health care centre at Vadu (~50 km from Pune city) and 116 pregnant women 
from the antenatal clinic of King Edward Memorial Hospital, Pune, at routine first trimester 
clinics. Pregnant women were recruited unselected, sequentially, as they attended ante-natal 
clinics. Women with multiple pregnancy, congenital anomaly of the fetus or a risk factor such 
as previous Caesarean section, fetal death, neonatal death; preeclampsia, hypothyroidism or a 
chronic medical condition (diabetes, hypertension, infective illness, etc.) were excluded. 
Ethical permission for the study was obtained from KEM Hospital Research Centre’s ethics 
committee and all women provided written consent. 
 
Dietary assessment 
A trained nutritionist assessed maternal diet at 17 and 34 weeks of pregnancy using a semi-
quantitative food frequency questionnaire (FFQ), based on local practices and validated for 
the Indian population
(41)
, to obtain the frequency of commonly consumed food items. Iodine-
rich foods (milk, milk products, seafood including fish and dry fish, and egg) were identified 
using Indian food composition tables
(42)
. Milk was either cow’s or buffalo’s milk. Milk 
products included ghee, butter, curds, cheese (though cheese is very rarely consumed). 
Seafood included all types of fish and dry fish. For each food group, daily, weekly or 
monthly frequency of consumption of individual foods was recalled since the previous visit 
of the subject. This frequency was summed to give a composite score of frequency of 
consumption per month. Frequent consumption was defined as equal to or greater than twice 
a week. Although data was collected for most of the iodine rich food items, the use of iodized 
salt was not recorded. Data were not available for use of iodine-fortified products. 
 
Maternal measurements  
Demographic data including Standard of Living Index (SLI)
(23)
, location (urban or rural) and 
educational level (in years) were collected at 17 weeks. Gestation was confirmed by 
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ultrasound measurement at all appointments. Standard anthropometric measurements were 
made and bioimpedance measurement using MultiScan 5000 (Bodystat Ltd, Isle of Man, UK) 
following standard procedure
(43)
.  
 
At each visit, fasting blood samples from the antecubital vein were collected in the sitting 
position, in an EDTA Vacutainer. Haematological measurements were carried out as reported 
previously
(40,41,43)
.   
 
Fresh fasting urine samples were obtained from 166 of the 234 participants, and were 
collected into sterile sealed containers, and frozen at -70
o
C at 17, 28 and 34 weeks gestation 
(132, 31 and 151 urine samples, respectively).  Specifically, samples at both 17 and 34 weeks 
were collected for 117 participants. The urine samples collected at 28 weeks are not 
described here, and only included for adjustment purposes (see statistical methods). No dip-
stick testing was performed, as it has been shown to affect iodine measurements
(44)
.  Urinary 
iodine concentration was measured using the simple Microplate Method (Bioclone Urinary 
Iodine Assay Kit) based on the Sandell-Kolthoff reaction using Victor System (PerkinElmer, 
Turku, Finland). Coefficient of variation is quoted by the manufacturer as 9.2% for low 
values and <6% for medium and high values, both inter- and intra-batches. Samples were 
analysed in duplicate and iodine concentrations were calculated with reference to external 
standards.  
 
Neonatal measurements 
Detailed neonatal anthropometry was conducted at birth. Birth weight (to the nearest 
0.001kg, ATCO Pvt. Ltd, Mumbai, India), length (to nearest 0.1 cm, using Pedobaby, ETS 
J.M.B., Brussels, Belgium) and skinfolds (to the nearest of 2mm using Harpenden’s skin 
calliper, Chasmors Ltd, London, UK) were measured immediately following birth. Follow-up 
anthropometry and data on breast feeding were collected at 3, 6, 12 and 24 months. 
Anthropometric measurements were recorded in duplicates by trained observers, using 
standardized methods. The coefficient of variation between the observers for different 
measurements was 2%. 
Cord blood was collected at birth from the placental end of the cord. The blood was 
centrifuged at 2500 g for 15 min at 4°C within 1 h of collection and plasma was stored at 
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70°C until further analysis. Cord plasma glucose and insulin were analysed as per the protocol 
used for maternal measurements.  Data on Social Interaction Score of babies were collected 
at 24 months, as previously described
(45)
.   
 
Statistical methods  
Data are presented as mean (SD) or median as appropriate for continuous variables, or count 
and frequencies for discrete variables. Normality of continuous data was tested with the 
Shapiro-Wilks test. Urinary iodine concentration data at 17 and 34 weeks were skewed, and 
median UICs are reported for comparison against WHO criteria (Table 1).  
Repeat UIC samples, available for 122 out of 166 participants (n=2 samples for 96 women, 
n=3 samples for 26 women) were used to generate adjusted distributions accounting for day-
to-day (within person) variations
(46)
 following the detailed National Research Council 
approach
(47)
 as used by Mackerras et al.
(48) 
(with the caveat that these samples were collected 
in pregnancy at different gestational stages). This enabled the use of (adjusted) UIC quartiles 
to group cases to investigate impact on maternal and neonatal characteristics.  
Comparisons between the lowest and highest quartiles (defined using the adjusted 
distributions) were made using the Student’s t-test and χ2 test.  Multivariate linear regression 
was carried out with UIC (17 and 34 weeks, quartiles based on adjusted distributions) and 
maternal characteristics (maternal age, location, socio-economic status (SLI score), 
educational level, parity, and for infant outcomes only, offspring gender, gestational age and 
feeding mode) as predictors. Neonatal and maternal parameters which differed significantly 
between lowest and highest UIC quartiles at 17 and 34 weeks (t-test, threshold p<0.1) were 
selected as outcome measures. Predictors were removed sequentially from the model 
according to lack of contribution. 
Since this study was hypothesis-generating, p<0.05 was assumed statistically significant, 
without adjustment for multiple correlations. Analyses used SPSS 18.0 (SPSS Inc. Chicago, 
US). 
 
Results 
The median urinary iodine values of women at 17 and 34 weeks gestation were 203 and 211 
µg/L respectively. Individual values ranged from 26 to 800 µl/L. Distributions of crude 
(unadjusted) urinary iodine at both 17 and 34 week gestation are shown in Figure 1, along 
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with the corrected distribution obtained by applying the NRC method. There was no 
correlation between the two UI measurements, either adjusted (p=0.681) or not (p=0.546), 
indicating that UI varied within individuals substantially through pregnancy. However, 24% 
of the women who had a UIC in the lowest quartile at 17 weeks had a follow-up 
measurement in this same lowest quartile at 34 weeks. Meanwhile, 34% of the women who 
had a UIC in the highest quartile at 17 weeks had a follow-up measurement in this same 
highest quartile at 34 weeks. 
 
Maternal characteristics and measurements 
Maternal characteristics at 17 and 34 weeks are shown in Tables 2 and 3. There was no 
difference in maternal age, location or parity between lowest and highest quartiles at either 17 
or 34 weeks. Educational status and socio-economic status (Standard of Living Index - SLI) 
was however significantly higher for those in the highest UIC quartile at 34 weeks (p<0.05). 
Maternal measurements carried out during pregnancy (fasted insulin levels, insulin resistance 
(HOMA-R), fat mass (BIA), Vitamin B12 and haematological measures) did not differ 
between lowest and highest quartiles at either 17 or 34 weeks, except for the mean 
corpuscular haemoglobin concentration being higher for those with UIC the lowest quartile at 
34 weeks (p=0.021).  
 
Diet and urinary iodine 
The consumption of milk products was significantly higher for those with UIC in the highest 
quartile at week 34 (p=0.002, Table 4). No other nutritional parameters differed for those 
who had UIC between lowest and highest quartile. 
Entering the four main class of iodine-rich foods monitored (milk, milk products, eggs and 
fish) in a multiple linear regression model showed that adjusted UIC at 34 weeks was higher 
by 0.73 µg/L (CI 0.33-1.12) for each extra serving of milk product consumed, after adjusting 
for SLI and maternal educational status.  The R
2
 value of this multiple regression model for 
adjusted UIC was however only 0.13, leaving a large proportion of variance unexplained.   
 
Influence of maternal urinary iodine on neonatal and infant development 
measurements 
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Neonatal and infant development measurements are shown in Table 5 according to maternal 
UI status at 17 and 34 weeks. Duration of exclusive breastfeeding did not differ between 
infants whose mothers had UIC in lowest and highest quartiles at either 17 or 34 weeks (6 
and 5 months, respectively, p>0.05). Amongst the offspring measures at birth (gestation, 
placental weight, birth weight, neonatal length, abdomen circumference, mid upper arm 
circumference subscapular and triceps skinfolds), there were no difference between the 
lowest and highest quartiles of maternal UIC at either 17 or 34 weeks. There was also no 
difference between cord plasma glucose and insulin between the two extreme quartiles for 
maternal UIC.  
Similarly, no differences were observed for any of the infant measures at 3 or 6 months, 
between the lowest and highest quartiles of maternal UIC.  
Among infants at age 12 months there were significant differences in the subscapular and 
triceps skinfolds beween those, born to mothers with UIC in the lowest and highest quartiles 
at 34 weeks, (both measures p=0.01).  These differences were also seen at 24 months (triceps 
skinfold p=0.02, subscapular skinfold p=0.04).  The abdominal circumference of infants at 24 
months was significantly different if the maternal UIC at 17 weeks was in the lowest 
compared to the highest quartile (p=0.03). 
 
Multiple regression analyses 
Maternal adjusted UIC at 17 and 34 weeks were entered in multiple linear regression models 
(alongside maternal age, location, education status, SLI, parity and offspring gender) to 
predict selected infant outcomes which were significantly different according to maternal 
iodine status (Table 5). UIC at 17 weeks did not predict abdominal circumference at 24 
months (p=0.055). UIC at 34 weeks did not predict triceps skinfold at 12 months (p=0.07), or 
subscapular skinfold at 24 months (p=0.185). UIC at 34 weeks was however a significant 
predictor of subscapular skinfold at 12 months (p=0.021, with a decrease of 0.006 cm for 
every extra µg/L UIC) and triceps skinfold at 24 months (p=0.035, with a decrease of 0.006 
cm for every extra µg/L UIC). These regression models accounted for only a very small 
proportion of the variance observed for each outcome (4% and 3.2%, respectively). 
 
Discussion 
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Iodine deficiency is one of the WHO nutritional priorities
(30)
.  It is estimated to cause a global 
loss of 13.5 IQ points at population level
(49)
, constituting the world's greatest single cause of 
preventable brain damage and mental retardation
(50)
. Iodine deficiency is still the most 
widespread cause of maternal hypothyroxinemia in Western societies. Detection at birth, by 
TSH estimation, is unlikely to identify mild iodine deficiency and would fail to identify those 
exposed to a period of iodine deficiency earlier in pregnancy, at a time probably too late for 
the treatment to normalise development. It is therefore possible that many minor learning 
disabilities may be preventable by advising women to take iodine supplements as soon as 
pregnancy starts, or earlier if possible
(50)
. 
The median urinary iodine values, 203 and 211 µg/L found in the present study at 17 and 34 
weeks respectively, lie in the ‘adequate’ (150-250µg/L) range for pregnant populations, 
implying that iodine deficiency is unlikely to be a frequent problem in this population
(30)
. Our 
results contrast with the study of tribal Indian pregnancies by Menon and Skeaff, who found 
median UICs of 106 and 71 µg/L at 17 and 34 week of pregnancy, respectively
(15)
. The 
difference between the UICs measured in each area of the same country highlights the 
geographical variation which may be due to cultural / dietary habits, which could include 
availability of iodine-fortified products and proximity to the sea and access to fish /seafood 
(Pune is less than 150km / 2 hours drive from the sea, while Ramtek is over 750km / 11hours 
drive from the sea). 
None of the women studied had overt iodine deficiency, with hypothyroidism, either among 
the 151 from whom samples were available for the present study, or among the 200 women 
who took part in the complete IAEA survey
(40)
, as hypothyroidism was an exclusion criterion. 
There was a wide range of individual values, from 26 to 800 µg/L, which cannot be explained 
completely on the basis of the limited dietary information available.  It is possible that some 
consumed iodine-rich food products intermittently, including iodized salt, but the significant 
association of urinary iodine with dairy food consumption assessed by the “Milk Product 
Score” confirms the importance of milk and dairy foods for iodine intake in this Indian 
population. Iodine is present at about 300-400 µg/L in milk
(51) 
and was shown to sometime 
occur at higher concentration in indian milk samples (ranging 26-604 µg/L)
(52)
.  Although 
present in many milk-based foods such as yoghurt and ice-cream, high intake of milk 
products is unlikely to account for the highest recorded urinary iodine concentration of 800 
µg/L (there was no iodine contamination of our samples from dip-stick testing).   
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A limitation of the present research is its size, small in epidemiological terms, however, the 
study was conducted in an area believed to include a proportion at possible risk from iodine 
deficiency, with a sample size on par with other similar studies
(15)
. The results cannot be 
regarded as quantitatively definitive, in a sample of 166 pregnant women from two Indian 
antenatal clinics, but the subjects were unselected and likely to be representative of the 
region.  Moreover, our sample size at each time point should afford us a precision range of 
±10% (95% CI)
(53)
.  The distributions of the UIC at 17 and 34 weeks were also corrected for 
day-to-day (within person) variations using the NRC method relying on repeated spot 
measurements in the same individuals, as described in a recent review
(46)
 and applied in 
another cross-sectional survey of iodine status
(48)
, with the caveat that these samples were 
collected at different gestational time points. This partly addresses the issue associated with 
small sample size
(48)
 and enabled us to use extreme quartiles to compare the maternal and 
infant characteristics of our population.  
UIC (adjusted or not) at 17 and 34 weeks did not correlate between the two gestational time-
points, indicating that iodine status fluctuates and that sustained exposure to toxic or 
extremely low amounts is unlikely. However, a few women (24%) who had UICs in the 
lowest quartile at 17 weeks remained in this quartile at the subsequent time point, while 34% 
of those with UICs in the highest quartile at 17 weeks had UIC in the same highest quartile at 
34 weeks. The lowest level we recorded, at 26 µg/L would almost certainly lead to overt 
hypothyroidism if maintained.  Samples were measured as “spot” concentrations, the most 
reliable indicator of iodine status for a population
(54) 
and would not have been biased 
downwards, as commonly occurs through having incomplete 24-hour collections.  However, 
spot urine samples are not suitable to establish individual iodine status.   
The biochemical and physiological measurements made, to assess growth and both metabolic 
and social developments were made by highly trained and reliable staff, as part of a IAEA-
funded study on determinants of subsequent metabolic syndrome
(40)
. It has proved possible to 
conduct medium to long-term follow-up studies on the offspring of carefully characterised 
pregnancies in this setting. This study adds to a number of other recent papers reporting 
iodine status in pregnancy
(2,16,31,55-57)
. The clinical/pathological effects of overt 
hypothyroidism are insidious, and commonly go undetected.  Any adverse effects of mild 
iodine insufficiency in pregnancy are likely to be very small, and slow to develop.  Indeed, 
the reported impact of maternal UIC on clinical offspring outcomes is weak, and not 
consistent (as expected in a population which we found out to be iodine sufficient). Our 
observations suggest that iodine status reflects measures of diet quality, as well as educational 
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status and social position which could affect growth and development both via poorer diet 
and by other mechanisms.   
This study was not powered to detect associations between maternal iodine status and 
neonatal or infant developmental outcomes: while some difference in neonatal outcomes 
identified according to maternal UIC, these outcome measures were not successfully 
predicted by maternal UIC during pregnancy (alongside other independent variables such as 
location, gender of offspring, education, feeding mode). Given the frequency of low median 
urinary iodine figures emerging world-wide in pregnancy (below the WHO cut-off of 
150µg/L), without clear evidence for detriment in most cases, there is a need for a large 
enough study to exclude detriment from subclinical iodine insufficiency, potentially to revise 
the WHO criterion.  
There are many reasons for poor fetal growth, besides low iodine status, which can interfere 
with thyroid function. Iodine deficiency is more common in younger, and multiparous 
women, and in smokers.  Smoking also impairs fetal growth and can cause goitre, and part of 
this mechanism is by blocking thyroxine synthesis. Thiocyanate is a goitrogenic metabolite of 
cyanide found in tobacco (and also in some foods such as cabbage and broccoli, as 
isothiocyanate)
(58,59)
.  However, smoking, albeit rare among Indian women, can cause 
competitive inhibition of iodide transport into the cell, causing increased TSH which in turn 
causes overgrowth of the thyroid gland, producing goitre
(58)
. None of the women recruited in 
this study were smokers, and the consumption of goitrogenic foods was not monitored, 
however these factors need to be considered when exploring the topic of iodine status and 
thyroid function. 
Our data also suggest that women do have occasional consumptions of very high iodine 
foods, with corresponding occasional high urinary iodine concentrations – up to 800 µg/L.  
They cannot be fully explained on the basis of the dietary information obtained in this study, 
and may relate to the (occasional) consumption of food very high in iodine or iodised-
foodstuff. There is no report of iodine levels in tap-water for this region. It is possible that 
these intermittent consumptions (with ample storage in the thyroid) are sufficient to maintain 
adequate iodine stores, although the usual dietary intakes, and urine concentrations are low.  
This understanding of iodine and thyroid physiology explains the recent demonstration that, 
in order to determine the iodine status of individuals, at least ten separate urinary iodine 
measurements are necessary
(53,60)
. The fact that dietary iodine need only be consumed 
intermittently also explains the way in which the WHO/UNICEF recommendations are 
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formulated
(30)
.  A urinary iodine below 100 µg/L, or 150 µg/L in pregnancy, does not 
categorise that individual as deficient: instead, an “iodine-deficient population” is considered 
to be one whose median for the population is below these cut-offs, in which case there are 
likely to be some individuals with clinical deficiency.  Conversely, a population with median 
urinary iodine above these values is unlikely to contain many individuals who are clinically 
deficient. Anxiety has arisen from several reports of (high) prevalence of iodine deficiency in 
the Indian population and elsewhere. However, it appears that several of the prevalence 
figures in these reports are based on the proportion of individuals with a spot sample UIC 
below the population cut-off (100 or 150 µg/L), a misinterpretation of the use of the WHO 
criterion for ‘population deficiency’(61). Statistical methods for the adjustment of the UIC 
distribution obtained following the collection of repeat spot samples are not frequently 
reported or used
(46,48)
 and the lack of validation of these methods in specific populations make 
their use subject to a number of caveats; however, they can be useful to describe sub-groups 
in cross-sectional studies. The adjustment procedure had very limited impact on the 
population UIC median (the raw, unadjusted median reported were 203 and 211 ug/L at 17 
and 34 weeks, respectively, against 211 and 214 ug/L for the adjusted medians), but allowed 
the use of quartiles to group cases. Finally, the terminology of the WHO/UNICEF document 
is confusing: it could be clearer to refer to “population iodine insufficiency”, and to reserve 
the medical term “deficiency” to a clinical diagnosis.  
Our study did not monitor TSH during pregnancy since hypothyroid women were excluded 
from the start; TSH rises with overt iodine deficiency, but possibly too late to warn of 
insidious cognitive effects
(50)
. Our data can now provide the basis of a power analysis to help 
design a definitive study on subclinical iodine insufficiency and the growth and development 
of offspring.  It is possible that small Indian women have lower requirement for iodine than 
other countries.  They may be able to function better, and to be able to provide for pregnancy, 
on intakes below that which would result in adverse effects in large women. However, many 
young women need more iodine.  Whilst low-level iodine fortification of common foods, or 
drinks is certainly a valid, and evidence-based, approach (notwithstanding the specific debate 
about the safety of promoting salt which is fortified with iodide), simple dietary changes 
could help.  Our data confirm the importance of milk and dairy foods as iodine sources, 
especially when fish is not consumed.  Milk is widely available and just 600 mL of milk or 
yoghurt/day provides the necessary 250 µg iodine.  Iodine-rich foods may not need to be 
consumed daily to provide iodine since it is stored in the body.  
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Table 1: Epidemiological criteria for assessing iodine status of the pregnant population 
based on the median or range in urinary iodine concentrations 
 
 
Population group 
Median urinary iodine 
concentration (µg/l) 
 
Iodine intake 
Pregnant women 
< 150 Insufficient 
150 – 249 Adequate 
250 – 499 Above requirements 
≥ 500 Excessive b 
 
b The term “excessive” means in excess of the amount required to prevent and control iodine 
deficiency – not necessarily a damaging excess. 
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Table 2: Characteristics of mothers at 17 and 34 weeks of pregnancy (Maharashtra, 
India, 2004-2006) 
 
 17 weeks (n=132) 34 weeks (n=151) 
Age, y 22.6  (3.7) -  
Height, cm 154.1  (5.4) 154.2 (5.3) 
Weight, kg 47.3  (6.5) 54.5  (7.3) 
Education, y 11.2  (3) 11.1  (3.1) 
Standard of living index (SLI) Score  36.7  (8.2) 36.1  (8.5) 
Primi-parous 94  (71.2) 106 (70.2) 
Multi-parous 38  (28.8) 45 (29.8) 
Vegeterian 44  (33.3) 53 (35.1) 
Milk (frequently consumed)

n (%) 76  (57.6) 83 (55.0) 
Milk products (frequently 
consumed)

n (%) 
72 
(54.5) 
91 
(60.3) 
Fish (frequently consumed)

n (%) 11 (8.3) 14 (9.3) 
Eggs (frequently consumed)

n (%) 20 (15.3) 23 (16.7) 
Urinary iodine (raw UIC g/L)† 203 (752) 211 (774) 
     
Values are mean (SD), †median (range) 

frequently consumed - more than twice a week, Socio-economic status given by Standard of Living 
Index (SLI) score  
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Table 3: Maternal characteristics at 17 and 34 weeks according to adjusted UI status 
(Maharashtra, India, 2004-2006) 
 
    17 weeks   34 weeks 
    
<25
th
 centile 
(n=33)   
>75
th
 centile 
(n=33)   
<25
th
 centile 
(n=37)   
>75
th
 centile 
(n=38) 
Age, y 
 
22.4 (3.8) 
 
22.5 (3.6) 
 
22.3 (3.5) 
 
22.9 (3.9) 
Height, cm 
 
154.9 (6.4) 
 
154.0 (5.8) 
 
153.0 (4.8) 
 
154.3 (5.9) 
Weight, kg 
 
46.1 (5.8) 
 
46.6 (6.7) 
 
53.1 (5.4) 
 
54.9 (7.3) 
Education, y 
 
10.7 (2.4) 
 
11.6 (2.6) 
 
10.5 (3) 
 
12.0*  (2.9) 
Standard of living 
index (SLI) Score 
 
36.1 (6.9) 
 
36.3 (7.7) 
 
33.3 (8.3) 
 
38.3* (8.3) 
Primi–parous † 
 
21 (64) 
 
25 (76) 
 
25 (68) 
 
25 (66) 
Multi –parous † 
 
12 (36) 
 
8 (24) 
 
12 (32) 
 
13 (34) 
Urban setting † 
 
15 (45) 
 
15 (45) 
 
14 (38) 
 
19 (50) 
Rural setting †  18 (54)  18 (54)  23 (62)  19 (50) 
Values are mean (SD), or † n (%). *P<0.05, within the same gestation time. 
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Table 4: Average foods frequency consumption per month during pregnancy, at 17 and 
34 weeks according to adjusted UI status (Maharashtra, India, 2004-2006) 
 
    17 weeks   34 weeks   
    
<25
th
 
centile 
(n=33)   
>75
th
 
centile 
(n=33)   
<25
th
 
centile 
(n=37)   
>75
th
 
centile 
(n=38)   
Milk   12 (15)   21 (23)   13 (17)   13 (3)   
Milk products  14 (19) 
 
13 (13) 
 
10 (14) 
 
27* (29) 
 Fish  2 (5) 
 
1 (2) 
 
1 (3) 
 
0.5 (1) 
 Eggs   2 (3)  3 (6)  4 (7)  2 (3)  
Values are means (SD) of food frequency consumption per month. *P<0.05, within the same gestation 
time. 
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Table 5: Characteristics of offsprings according to maternal UI status (Maharashtra, 
India, 2004-2006) 
17 weeks   34 weeks 
Size  
<25
th
 centile 
(n=33)   
>75
th
 centile 
(n=33)   
p-
value   
<25
th
 centile 
(n=37)   
>75
th
 centile 
(n=38)   p-value 
At Birth                 
Weight (kg) 2.8 (0.4)  
2.7 (0.3) 
 
0.23 
 
2.8 (0.4) 
 
2.8 (0.3) 
 
0.95 
Length (cm) 48.6 (1.7)  
48.3 (1.9) 
 
0.54 
 
48.4 (2.1) 
 
48.9 (1.6) 
 
0.29 
Abdominal circ (cm) 29.1 (2)  
28.7 (2.4) 
 
0.49 
 
28.6 (2.3) 
 
29.3 (1.8) 
 
0.19 
Subscapular skinfold (mm) 4.0 (1.2)  
4.1 (0.9) 
 
0.78 
 
4.2 (1.2) 
 
4.2 (0.9) 
 
0.93 
Triceps skinfold (mm) 4.4 (1.1)  
4.4 (0.7) 
 
1.0 
 
4.6 (1) 
 
4.4 (0.8) 
 
0.52 
Cord insulin (mIU/L) 5.9 (5.9)  
6.1 (2.6) 
 
0.88 
 
8.0 (5.5) 
 
5.9 (3.7) 
 
0.1 
Cord plasma glucose 
(mg/dL) 
84.3 (28.7) 85.8 (26.4) 0.86 
 
89.6 (28.2) 99 (26.6) 0.18 
 
               
At 3 months                
Weight (kg) 5.6 (0.8)  
5.4 (0.7) 
 
0.32 
 
5.4 (0.7) 
 
5.5 (0.7) 
 
0.68 
Length (cm) 61.7 (2.5)  
61.1 (2.8) 
 
0.4 
 
60.4 (2.3) 
 
61.0 (2.8) 
 
0.31 
Abdominal circ (cm) 39.3 (2.1)  
38.3 (2.7) 
 
0.16 
 
38.7 (2.4) 
 
39.3 (2.5) 
 
0.27 
Subscapular skinfold (mm) 7.9 (1.8)  
7.4 (1.2) 
 
0.29 
 
8.1 (1.5) 
 
7.7 (1.7) 
 
0.29 
Triceps skinfold (mm) 8.5 (1.7)  
9.1 (1.3) 
 
0.13 
 
9.0 (1.3) 
 
8.9 (1.7) 
 
0.66 
 
               
At 6 months                
Weight (kg) 6.8 (0.9)  
6.8 (0.8) 
 
0.9 
 
6.8 (1) 
 
6.8 (0.7) 
 
0.8 
Length (cm) 66.7 (2.8)  
67.1 (3.2) 
 
0.62 
 
66.3 (3) 
 
66.7 (3.2) 
 
0.57 
Abdominal circ (cm) 41.1 (2.7)  
40.7 (2.8) 
 
0.59 
 
40.7 (2.6) 
 
40.8 (2.4) 
 
0.9 
Subscapular skinfold (mm) 7.2 (1.7)  
6.9 (1.4) 
 
0.57 
 
7.3 (1.8) 
 
6.8 (1.3) 
 
0.25 
Triceps skinfold (mm) 8.5 (2)  
8.7 (1.9) 
 
0.78 
 
8.7 (1.7) 
 
8.4 (1.9) 
 
0.41 
 
               
At 12 months                
Weight (kg) 8.2 (1.4)  
8.1 (1.1) 
 
0.73 
 
8.2 (1) 
 
8.3 (1) 
 
0.79 
Length (cm) 73.7 (4.2)  
74.1 (4) 
 
0.73 
 
73.9 (3.6) 
 
74.5 (3) 
 
0.46 
Abdominal circ (cm) 43.1 (3.6)  
42.4 (2.9) 
 
0.45 
 
43.0 (2.9) 
 
43.0 (3.3) 
 
0.98 
Subscapular skinfold (mm) 6.7 (2.2)  
6.1 (1.8) 
 
0.29 
 
7.1 (1.9) 
 
6.0 (1.1) 
 
0.01* 
Triceps skinfold (mm) 7.8 (2)  
7.6 (2.1) 
 
0.75 
 
8.0 (1.2) 
 
7.1 (1.3) 
 
0.01* 
 
               
At 24 months                
Weight (kg) 10.6 (1.6)  
10.2 (1.2) 
 
0.43 
 
10.4 (1) 
 
10.3 (1.2) 
 
0.61 
Length (cm) 85.3 (4.4)  
84.6 (4.3) 
 
0.6 
 
84.5 (3) 
 
85.4 (3.9) 
 
0.29 
Abdominal circ (cm) 46.5 (3.1)  
44.7 (2.5) 
 
0.03* 
 
45.5 (2.3) 
 
45.1 (2.6) 
 
0.55 
Subscapular skinfold (mm) 6.4 (1.4)  
5.9 (1.5) 
 
0.21 
 
6.4 (1.4) 
 
5.7 (1.1) 
 
0.04* 
Triceps skinfold (mm) 8.3 (1.5)  
8.1 (2.3) 
 
0.64 
 
8.7 (1.8) 
 
7.6 (2.1) 
 
0.02* 
Social Quotient Score 91 (6)  
92 (6) 
 
0.55 
 
92 (5) 
 
92 (6) 
 
0.79 
Mental development score 101 (8)  
98 (7) 
 
0.16 
 
97 (6) 
 
100 (6) 
 
0.12 
Motor development score 113 (5)  
111 (4) 
 
0.32 
 
112 (5) 
 
113 (4) 
 
0.2 
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Figure 1: Distributions urinary iodine concentration at (a) 17 weeks of pregnancy, and (b) 34 
weeks of pregnancy (Maharashtra, India, 2004-2006). Solid line: crude UICs; dashed lines: 
UICs corrected for within-person variation. 
 
 
 
